Other antibodies directed against the mucins MUC1, MUC2 and MUC4 should also be evaluated, since these proteins are heavily glycosylated, and altered glycosylation in cancer may influence the reactivity to such antibodies.45,46. The gene discussed is MUC2; the disease is cancer.